GlassScriptPhysician profile
Jorge S Kim
NPI 1982863759
$3,780.64
in general payments reported to CMS, 2019-2025
12 companies · $3,461 in 2025
The $3,461 reported for 2025 was more than what 92% of Pain Medicine (Physical Medicine & Rehabilitation) providers received nationally (typical 2025 total: $400).
See the full distribution for Pain Medicine (Physical Medicine & Rehabilitation)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $18.38 · 2024: $301 · 2025: $3,461.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,701 · Food and Beverage: $1,061.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,701.13 |
| Food and Beverage | $1,061.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spr Therapeutics, INC | $1,736.07 | 2024-2025 | Sprint Pns System |
| Stryker Corporation | $1,079.07 | 2022-2025 | Optablate, Mild Device Kit, Spinejack |
| Averitas Pharma INC. | $330.30 | 2024-2025 | Qutenza |
| Globus Medical, INC. | $224.49 | 2025 | Senza |
| Vertex Pharmaceuticals Incorporated | $115.04 | 2024-2025 | |
| Abbvie INC. | $88.98 | 2024-2025 | |
| Nevro Corp. | $71.46 | 2024 | Senza |
| Medtronic, INC. | $48.13 | 2025 | Intellis Adaptivestim |
| Saluda Medical Americas, INC. | $27.54 | 2024 | Evoke |
| Abbott Laboratories | $23.83 | 2024 | Proclaim |
| Avanos Medical | $18.20 | 2024 | Standard Rf Disposables |
| Collegium Pharmaceutical, INC. | $17.53 | 2024 | Belbuca |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jorge Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.